FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps Thousands of Sites, Less Than 100 Investigators: New Authorities Help FDA Maintain Oversight of Clinical Research FDA The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Why would a patient trust a peptide more than a statin? STAT